Company Filing History:
Years Active: 2016
Title: Bruce Stouffer: Innovator in Antibody Treatment
Introduction
Bruce Stouffer is a notable inventor based in Branchburg, NJ (US). He has made significant contributions to the field of medical treatments, particularly in the area of antibody therapies. His innovative work has led to the development of a unique method for treating diseases related to Interferon gamma inducible protein 10 (IP-10).
Latest Patents
Stouffer holds a patent for the invention titled "IP-10 antibody dosage escalation regimens." This patent outlines a method for treating IP-10-related diseases by administering a predetermined dosage of an anti-IP-10 antibody. The process involves detecting the antibody levels in the subject and adjusting the dosage accordingly to ensure effective treatment.
Career Highlights
Bruce Stouffer is currently associated with Bristol-Myers Squibb Company, where he continues to advance his research and development efforts. His work has been instrumental in enhancing therapeutic strategies for patients suffering from IP-10-related conditions.
Collaborations
Stouffer has collaborated with notable colleagues, including Allison Y Luo and Wendy L Trigona. These partnerships have fostered a collaborative environment that promotes innovation and the sharing of ideas in the field of antibody research.
Conclusion
Bruce Stouffer's contributions to the field of antibody treatments exemplify the impact of innovative thinking in medicine. His patent for the IP-10 antibody dosage escalation regimen represents a significant advancement in therapeutic approaches.